Latest News in the pharma Industry

Policy & Regulation

Rx-360 Summary of the EU GDP Questions and Answers

Rx-360 Summary of the EU GDP Questions and Answers

11 Apr 2014

Read more 
BMS Submits NDAs for Daclatasvir and Asunaprevir to US FDA for the Treatment of Hepatitis C

BMS Submits NDAs for Daclatasvir and Asunaprevir to US FDA for the Treatment of Hepatitis C

9 Apr 2014

Read more 
FDA Approves New Hand-Held Auto-Injector to Reverse Opioid Overdose?

FDA Approves New Hand-Held Auto-Injector to Reverse Opioid Overdose?

4 Apr 2014

Read more 
Hikma Announces Successful Resolution to US FDA Warning Letter at Eatontown Facility

Hikma Announces Successful Resolution to US FDA Warning Letter at Eatontown Facility

4 Apr 2014

Read more 
FDA Approves First Sublingual Allergen Extract for the Treatment of Certain Grass Pollen Allergies?

FDA Approves First Sublingual Allergen Extract for the Treatment of Certain Grass Pollen Allergies?

3 Apr 2014

Read more 
FDA Advisory Committee Recommends Approval of Afrezzar, MannKind Corporation's Investigational Drug to Treat Diabetes

FDA Advisory Committee Recommends Approval of Afrezzar, MannKind Corporation's Investigational Drug to Treat Diabetes

3 Apr 2014

Read more 
FDA Approves Biogen Idec's ALPROLIXT

FDA Approves Biogen Idec's ALPROLIXT

31 Mar 2014

Read more 
Rx-360 Summary of FDA's Guidance on Allowable Fill Volume Excesses in Vials

Rx-360 Summary of FDA's Guidance on Allowable Fill Volume Excesses in Vials

26 Mar 2014

Read more 
Forxiga Receives Regulatory Approval in Japan for the Treatment of Type 2 Diabetes

Forxiga Receives Regulatory Approval in Japan for the Treatment of Type 2 Diabetes

24 Mar 2014

Read more 
CHMP Recommends Empagliflozin for Approval to Reduce Blood Sugar Levels in Adults with Type 2 Diabetes in Europe

CHMP Recommends Empagliflozin for Approval to Reduce Blood Sugar Levels in Adults with Type 2 Diabetes in Europe

24 Mar 2014

Read more 
Biogen Idec Receives Notificati?on of PDUFA Date Extension for Plegridy (Peginterf?eron Beta-1a)

Biogen Idec Receives Notificati?on of PDUFA Date Extension for Plegridy (Peginterf?eron Beta-1a)

18 Mar 2014

Read more 
FDA Approves Merck’s NOXAFIL (Posaconazole) Injection (18 mg/mL) for Intravenous Use

FDA Approves Merck’s NOXAFIL (Posaconazole) Injection (18 mg/mL) for Intravenous Use

17 Mar 2014

Read more